2-((2S)-Pyrrolidin-2-yl)-5-(4-(4-(2- ((2S)-pyrrolidin-2-yl)-1H-imidazol -5-yl)phenyl)phenyl)-1himidazole tetrahydrochloride
Catalog No.: BK8QE9
CAS.RN：1009119-83-8
Molecular Formula: C26H32Cl4N6
Molecular Weight: 570.38 g/mol
Purity: NLT 98%
Synonyms:
Intermediates of Daclatasvir
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA48B5 | Daclatasvir API | 1009119-64-5 |
| BK94B1 | Daclatasvir dihydrochloride | 1009119-65-6 |
| BK76B8 | 4,4'-Bis(2-bromoacetyl)biphenyl | 4072-67-7 |
| BK33YL | di-tert-butyl (2S,2'S)-2,2'-(4,4'-biphenyldiylbis(1H-imidazole-5,2-diyl))di(1-pyrrolidinecarboxylate) | 1007882-23-6 |
| BK8QE9 | 2-((2S)-Pyrrolidin-2-yl)-5-(4-(4-(2- ((2S)-pyrrolidin-2-yl)-1H-imidazol -5-yl)phenyl)phenyl)-1himidazole tetrahydrochloride | 1009119-83-8 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
